Clinically Important Drug Interactions with Anticoagulants

@article{Harder1996ClinicallyID,
  title={Clinically Important Drug Interactions with Anticoagulants},
  author={S. Harder and P. Th{\"u}rmann},
  journal={Clinical Pharmacokinetics},
  year={1996},
  volume={30},
  pages={416-444}
}
  • S. Harder, P. Thürmann
  • Published 1996
  • Medicine
  • Clinical Pharmacokinetics
  • SummaryCoumarin derivatives combine 3 unfavourable properties which make them prone to potentially life threatening drug-drug interactions: (i) high protein binding; (ii) cytochrome P450 dependent metabolism; and (iii) a narrow therapeutic range.An entire list of drugs which are supposed to interact with coumarins (mostly with warfarin) comprises about 250 different compounds. Noteworthy are the interactions with cardiovascular or antilipidaemic drugs which are often coadministered with… CONTINUE READING
    227 Citations
    Clinically relevant drug interactions with antiepileptic drugs.
    • E. Perucca
    • Medicine
    • British journal of clinical pharmacology
    • 2006
    • 450
    • PDF
    Cytochrome P450-mediated cardiovascular drug interactions
    • A. Scheen
    • Medicine
    • Expert opinion on drug metabolism & toxicology
    • 2011
    • 24
    Comparative Pharmacokinetics of Vitamin K Antagonists
    • M. Ufer
    • Medicine
    • Clinical pharmacokinetics
    • 2005
    • 250
    The discovery of YM-60828: a potent, selective and orally-bioavailable factor Xa inhibitor.
    • 30

    References

    SHOWING 1-10 OF 183 REFERENCES
    Possible Interaction Between Warfarin and Fluconazole
    • 33
    Interaction of warfarin and nonsystemic gastrointestinal drugs
    • 74
    Active metabolites of acenocoumarol: do they contribute to the therapeutic effect?
    • 13
    Potentiation of anticoagulant effect of warfarin by phenylbutazone.
    • 215
    Further elucidation of pharmacokinetic interaction between diltiazem and warfarin.
    • 12
    Norfloxacin Does Not Alter Warfarin's Disposition or Anticoagulant Effect
    • 32
    [Drug interactions in cardiovascular therapy].
    • J. Koch-weser
    • Medicine
    • Schweizerische medizinische Wochenschrift
    • 1976
    • 21